FOSUN PHARMA

Forecast & Rating7 analysts currently cover FOSUN PHARMA, with about 71.4% giving a positive rating — meaning they expect the stock to rise. The average price target is ¥34.46, about 49.8% upside from the current price of ¥23.00. Price targets range from ¥24.10 to ¥44.00 — a wide spread, showing clear disagreement over just how much FOSUN PHARMA can rise. Historically, about 41.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study FOSUN PHARMA closely still see room for the stock to rise. Data as of Jul 25, 2026; for reference only and not investment advice.